1 INCLIVA, Biomedical Research Institute, Department of Medical Oncology, Hospital Clínico Universitario, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
2 INCLIVA, Biomedical Research Institute, Department of Medical Oncology, Hospital Clínico Universitario, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: andres.cervantes@uv.es.